Der Hippocampus ist eine von zwei Gehirnregionen, in der zeitlebens kontinuierlich neue Nervenzellen gebildet werden. Er spielt eine wichtige Rolle bei der Gedächtniskonsolidierung und wird mit der funktionellen Entstehung neurodegenerativer Erkrankungen in Verbindung gebracht. Strukturveränderungen im erwachsenen Gehirn, die mit einer Depression einhergehen, sind laut Literatur auf einen geringen Serotoninspiegel und reduzierte hippocampale Neurogenese zurückzuführen. Selektive Serotonin-Wiederaufnahmehemmer (SSRI) erhöhen die Serotoninkonzentration im synaptischen Spalt und üben einen positiven Effekt auf die adulte Neurogenese aus. In der vorliegenden Arbeit wird untersucht, wie Veränderungen in der Serotonin (5-HT)-Neurotransmission durch einmalige oder chronische Gaben von Fluoxetin und speziellen Agonisten und Antagonisten für die Serotoninrezeptoren 5-HT1a und 5-HT2 in der erwachsenen Maus die Proliferation und Differenzierung von neugebildeten Nervenzellen im Gyrus dentatus beeinflussen. Die Ergebnisse zeigen, dass ein konträres Agieren beider Rezeptoren zu einem ausgewogenen Serotoninspiegel führt. 5-HT1a- und 5-HT2c-Rezeptoren haben einen Einfluss auf das Überleben neugebildeter Nervenzellen, wobei sie unterschiedliche Entwicklungsstadien innerhalb der adulten Neurogenese kontrollieren. Die vorliegende Arbeit bekräftigt außerdem, dass die chronische Gabe von Fluoxetin die adulte Neurogenese steigert. / The hippocampus as one region with ongoing neurogenesis throughout life contributes to the formation of long-term memory and has also been implicated in the pathology of major depression. Studies suggest that depression might be due to decreased levels of serotonin and reduced neurogenesis in the adult brain and that the beneficial effects of selective serotonin reuptake inhibitors would require adult hippocampal neurogenesis. Here, I investigated how modulation of serotonergic neurotransmission by acute and chronic treatment with the antidepressant fluoxetine, and selective serotonin receptor agonists and antagonists in adult mice influences precursor cell activity during development. I focused on 5-HT1a and 5-HT2 receptors as major mediators of serotonin action. The present findings suggest that an opposed action of 5-HT1a and 5-HT2c receptor subtypes result in a balanced regulation of serotonin levels in the dentate gyrus. Both receptors differentially affect intermediate cell stages in adult hippocampal neurogenesis and play an important role in the survival of newly generated neurons. Furthermore, this study confirms that chronic fluoxetine treatment increases adult neurogenesis. In conclusion, the latency of onset of fluoxetine action can be explained by a balanced interplay of 5-HT1a and 5-HT2c receptor subtypes.

Ce travail s'inscrit dans l'étude du réseau neuronal responsable de l'activation corticale au cours du sommeil paradoxal (SP) chez le rongeur. Dans la première partie de ma thèse, j'ai participé à la démonstration que cette activation est limitée à quelques structures limbiques déterminantes pour l'apprentissage, dont le gyrus dentelé de l'hippocampe (GD). Nous avons ensuite montré que l'activation du GD en SP est due à une projection issue du noyau supramammillaire (Sum). J'ai ensuite montré en combinant l'hybridation in situ d'un marqueur des neurones glutamatergiques et GABAergiques et l'immunohistochimie du FOS que les neurones du Sum latéral actifs en SP sont à la fois glutamatergiques et GABAergiques (GLU/GABA). Enfin, j'ai montré que l'augmentation du nombre de neurones FOS+ dans le GD dorsal en SP est abolie après la lésion neurochimique du Sum. De plus, la lésion du Sum induit une nette réduction de la densité de fibres glutamatergiques dans le GD dorsal. Ces résultats indiquent que les neurones du GD dorsal sont activés en SP par les neurones GLU/GABA du Sum latéral. Le deuxième objectif de ma thèse a été de déterminer la fonction de cette voie en SP. Ainsi j'ai utilisé la technique d'optogénétique afin d'inactiver ou activer les fibres GLU/GABA provenant du Sum localisées dans le GD dorsal au cours du SP. Nos résultats montrent que l'activation de ces fibres en SP induit une augmentation de la fréquence et de la puissance du thêta enregistré dans le GD. Ces résultats indiquent que la voie Sum-GD dorsal contrôle le thêta hippocampique et soutiennent l'hypothèse d'un rôle de cette voie dans les processus de consolidation mnésique prenant place au cours du SP / During my PhD I studied the neuronal network responsible for cortical activation during paradoxical sleep (PS) in rodents. In the first part of my thesis, I participated to the demonstration that this activation is limited to a few limbic structures involved in learning, including the dentate gyrus of the hippocampus (DG). Then, we showed that the activation of DG during PS is due to a projection from the supramammillary nucleus (Sum). Besides, by combining the in situ hybridization of markers of GABAergic and glutamatergic neurons and FOS immunohistochemistry, I demonstrated that lateral Sum neurons active in SP are both glutamatergic and GABAergic (GLU/GABA). Finally, I showed that the increasing number of FOS+ neurons in the dorsal DG during PS is abolished by the neurochemical lesion of the Sum. In addition, the Sum lesion induces a clear reduction of the density of glutamatergic fibers in the dorsal DG. These results indicate that during PS, dorsal DG neurons are activated by GLU/GABA neurons located in the lateral Sum. The second aim of my thesis was to determine the function of this pathway during PS. To realize that, I inactivated or activated by optogenetics the Sum GLU/GABA fibers located in the dorsal GD during SP. Our results show that the activation of these fibers during SP induces an increase in the theta frequency and power recorded in the dorsal DG. These results indicate that the Sum-dorsal DG-pathway modulates the hippocampal theta and supports the hypothesis of a role of this pathway in the memory consolidation process during SP

Every year over 2.5 million traumatic brain injuries (TBI) occur and are the leading cause of death and disability among adolescents. There are no approved treatments for TBI. Survivors suffer from persistent cognitive impairment due to posttraumatic tissue damage and disruption of neural networks which significantly detract from their quality of life. Posttraumatic cognitive impairment depends in part on the brain's limited ability to repair or replace damaged cells. Immature neurons in the hippocampus dentate gyrus, a brain region required for learning and memory, are particularly vulnerable to TBI. Insulin-like growth factor-1 (IGF1) is a potential therapeutic for TBI because it is a potent neurotrophic factor capable of mediating neuroprotection, neuro-repair, and neurogenesis. We hypothesized that conditional IGF1 overexpression in the mouse hippocampus following experimental controlled cortical impact injury (CCI) would enhance posttraumatic neurogenesis chronically. To this end, conditional astrocyte-specific IGF1 overexpressing mice (IGFtg) and wild-type (WT) mice received CCI or sham injury. The proliferation marker BrdU was used to label neurons born the first week after injury. Six weeks after injury, when surviving posttrauma-born neurons would be fully developed, we counted proliferated cells (BrdU+) and the subset expressing a mature neuronal marker (NeuN+/BrdU+) in the hippocampus. We also assessed cognitive performance during radial arm water-maze reversal (RAWM-R) testing, a neurogenesis-sensitive assay. IGF1 promoted end-stage maturity and decreased mis-migration of neurons born after trauma. These effects coincide with IGF1 induced improvements in performance on neurogenesis sensitive cognition following TBI. Mammalian target of rapamycin (mTOR), an early signaling molecule downstream of IGF1, has been identified as a potential target for TBI interventions because of its regulatory role in neuronal plasticity and neurogenesis. However, recent studies have also reported maladaptive plasticity and recovery associated with posttraumatic mTOR activation. It is imperative to elucidate the mechanism of action of IGF1 during pre-clinical evaluations. We hypothesized that IGF1 mediates posttraumatic neurogenic effects through IGF1 induction of mTOR activation. We injured cohorts of IGFtg and WT mice and harvested their brains for immunohistochemistry to assess IGF1 overexpression effects on posttraumatic mTOR activation at 1, 3, and 10 days post-injury (dpi). We found that IGF1 upregulated mTOR activation following TBI in a region-specific manner at 1 and 3dpi. To determine if IGF1 regulated differentiation and arborization through the mTOR pathway, injured WT and IGFtg mice received daily i.p. injections of rapamycin (10mg/kg), the inhibitor of mTOR, or its vehicle for 7 days. Vehicle and rapamycin administration began 3dpi, after the cells dividing at the peak of posttraumatic proliferation were labeled with BrdU. IGF1 enhancement of posttraumatic neurogenesis was not dependent on mTOR activation. In summary, IGF1 directs newborn neuron localization, promotes end-stage maturation, and chronically improves cognition. IGF1 can stimulate posttraumatic neurogenesis and plasticity independent of mTOR activation. These data suggest that IGF1 can stimulate neuron replacement following trauma-induced hippocampal neuron loss and cognitive improvement. Further studies should investigate IGF1 and mTOR inhibition as a combination therapy for neurorehabilitation.

No description available.

Only 200 years ago, virtually nothing was known about the biological workings of the mind. Today, there is a deep (though far from complete) understanding of the cellular and molecular mechanisms underlying the encoding of memory, arguably the most fundamental aspect of a cognitive being. In this thesis, I describe experiments that help complete this understanding and identify the very first molecules underlying curiosity. By using an inducible rtTA2-M2 double transgenic system to selectively overexpress the calcium sensor Ncs1 in the adult murine dentate gyrus, I created an animal with facilitated long-term potentiation, enhanced rapid acquisition of spatial memory and greater curiosity. These phenotypes are reversed by direct infusion of a small membrane-permeant interfering peptide designed to block complex formation between NCS-1 and Dopamine type-2 receptors (D2 receptors). Pharmacological antagonism of D2 receptors also attenuates plasticity in wild-type mice and direct antagonism of D2 receptors in the dentate of cannulized wild-type mice prevents spatial memory formation. Conversely, application of a dominant negative NCS-1 peptide reduces synaptic transmission in the dentate gyrus and impairs spatial fear learning. Far less understood than the mechanisms governing learning and memory, are the mechanisms used by the brain to generate curiosity. Strikingly, Ncs1 overexpressing mice also demonstrate increased exploratory behaviours in a variety of novel, non-fearful environments. But they do not explore novel fearful environments any more than their littermate controls. I argue that the specificity of this phenotype represents an effect on curiosity, thereby identifying NCS-1 and D2 receptors as the first known regulators of this primordial mental state. I propose that the generation of curiosity is a fundamental feature of the nervous system and is upstream of learning and cognition. As such, molecular cascades involved in curiosity likely also play roles in mental illnesses. To investigate this theory, I generated an NCS-1 point mutant mouse line. NCS-1P144S/P144S mice show endophenotypes of schizophrenia and depression, supporting the link between curiosity and mental illness. I integrate my findings with the current literature and propose a means to investigate the role of NCS-1 in humans with mental illnesses.

No description available.

This study sought to determine whether the DG, CA3, and CA1 regions contain uniformly excitable populations and test the hypothesis that rapid addition of new, more excitable, granule cells in prepubescence results in a low activation probability (P1) in the DG. The immediate-early gene Homer1a was used as a neural activity marker to quantify activation in juvenile (P28) and adult (~5 mo) rats during track running. The main finding was that P1 in juveniles was substantially lower not only the DG, but also CA3 and CA1. The P1 for a DG granule cell was close to 0 in juveniles, versus 0.58 in adults. The low P1 in juveniles indicates that sparse, but non-overlapping, subpopulations participate in encoding events. Since sparse, orthogonal coding enhances a network’s ability to decorrelate input patterns (Marr, 1971; McNaughton & Morris, 1987), the findings suggest that juveniles likely possess greatly enhanced pattern separation ability. / ix, 51 leaves : ill. ; 29 cm

No description available.

Only 200 years ago, virtually nothing was known about the biological workings of the mind. Today, there is a deep (though far from complete) understanding of the cellular and molecular mechanisms underlying the encoding of memory, arguably the most fundamental aspect of a cognitive being. In this thesis, I describe experiments that help complete this understanding and identify the very first molecules underlying curiosity. By using an inducible rtTA2-M2 double transgenic system to selectively overexpress the calcium sensor Ncs1 in the adult murine dentate gyrus, I created an animal with facilitated long-term potentiation, enhanced rapid acquisition of spatial memory and greater curiosity. These phenotypes are reversed by direct infusion of a small membrane-permeant interfering peptide designed to block complex formation between NCS-1 and Dopamine type-2 receptors (D2 receptors). Pharmacological antagonism of D2 receptors also attenuates plasticity in wild-type mice and direct antagonism of D2 receptors in the dentate of cannulized wild-type mice prevents spatial memory formation. Conversely, application of a dominant negative NCS-1 peptide reduces synaptic transmission in the dentate gyrus and impairs spatial fear learning. Far less understood than the mechanisms governing learning and memory, are the mechanisms used by the brain to generate curiosity. Strikingly, Ncs1 overexpressing mice also demonstrate increased exploratory behaviours in a variety of novel, non-fearful environments. But they do not explore novel fearful environments any more than their littermate controls. I argue that the specificity of this phenotype represents an effect on curiosity, thereby identifying NCS-1 and D2 receptors as the first known regulators of this primordial mental state. I propose that the generation of curiosity is a fundamental feature of the nervous system and is upstream of learning and cognition. As such, molecular cascades involved in curiosity likely also play roles in mental illnesses. To investigate this theory, I generated an NCS-1 point mutant mouse line. NCS-1P144S/P144S mice show endophenotypes of schizophrenia and depression, supporting the link between curiosity and mental illness. I integrate my findings with the current literature and propose a means to investigate the role of NCS-1 in humans with mental illnesses.

No description available.